Profile
VERO ABT BSX-PA SYK MDT BSX
Company Name Venus Concept Inc. Abbott Laboratories Boston Scientific Corporation Stryker Corporation Medtronic plc Boston Scientific Corporation
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $3.95M $181.08B $175.45B $127.50B $114.09B $109.75B
Employees 0.30K 114.00K 45.00K 52.00K 95.00K 48.00K
CEO Mr. Rajiv Kanishka Liyanaarchchie De Silva Mr. Robert B. Ford Mr. Michael F. Mahoney Mr. Kevin A. Lobo Mr. Geoffrey Straub Martha Mr. Michael F. Mahoney
Ratings
VERO ABT BSX-PA SYK MDT BSX
Quant Rating Score 3 5 5 4 4
Quant Rating Neutral Strong Buy Strong Buy Buy Buy
Trading
VERO ABT BSX-PA SYK MDT BSX
Last Close $0.621 $104.09 $122.18 $334.68 $85.92 $74.65
High 52 $2.56 $120.98 $128.02 $358.71 $90.4 $74.65
Low 52 $0.61 $90.19 $120 $253.85 $69.43 $48.64
Price vs. 52 Week High -75.74 % -13.96 % -4.56 % -6.7 % -4.96 % 0 %
Price vs. 52 Week Low 1.8 % 15.41 % 1.82 % 31.84 % 23.75 % 53.47 %
Total Return
VERO ABT BSX-PA SYK MDT BSX
1 Month Return -23.8 % -2.97 % 0 % 2.84 % 8.1 % 10.87 %
3 Month Return -44.55 % -8.7 % 0 % -4.19 % 1.78 % 13.42 %
6 Month Return -66.97 % 4.56 % 0 % 16.06 % 14.93 % 37.38 %
9 Month Return -67.66 % 0.37 % 0 % 20.43 % 5.4 % 48.73 %
YTD Return -47.37 % -5.43 % 0 % 11.76 % 4.3 % 29.13 %
1 Year Return -73.8 % -4.44 % -4.1 % 17.28 % -3.82 % 39.17 %
3 Year Return 0 % -10.56 % 0 % 0 % -31.63 % 80.18 %
5 Year Return 0 % 37.38 % 0 % 0 % -1.88 % 100.19 %
Dividends
VERO ABT BSX-PA SYK MDT BSX
Dividend Yield Percentage (TTM) - 2.04 % - 0.93 % 3.21 % -
Dividend Paid and Capex Coverage Ration (TTM) -138.72 % 1.22 % 2.66 % 1.96 % 1.24 % 2.64 %
Dividend Per Share (TTM) - 2.12 % - 3.1 % 2.76 % -
Payout Ratio (TTM) - 64.35 % 6.1 % 34.48 % 87.07 % 0.79 %
Growth
VERO ABT BSX-PA SYK MDT BSX
Asset Growth -25.3 % -1.64 % 8.21 % 8.21 % -0.04 % 8.21 %
Gross Profit Growth -20.92 % -9.7 % 14.01 % 12.78 % -4.8 % 14.01 %
Revenue Growth -23.26 % -8.12 % 12.29 % 11.11 % -1.45 % 12.29 %
Revenue 3 Year -56.09 % 18.09 % 40.06 % 41.29 % 8.89 % 40.06 %
Revenue 5 Year -90.48 % 32.35 % 37.78 % 48.53 % 6.36 % 37.78 %
Revenue 10 Year -91.66 % 63.34 % 84.02 % 126.63 % 44.28 % 84.02 %
EBIT Growth 18.88 % -22.53 % 42.09 % 36.85 % -4.64 % 42.09 %
Net Income Growth 14.53 % -17.45 % 128.22 % 34.22 % -25.42 % 128.22 %
Net Income 3 Yeari Growth Per Share 79.82 % 29.73 % 1209.43 % 95.8 % -20.89 % 1209.43 %
Net Income 5 Yeari Growth Per Share 96.45 % 143.85 % -9.39 % -12.21 % 23.52 % -9.39 %
Net Income 10 Yeari Growth Per Share 96.95 % 97.66 % 1315.23 % 213.78 % -16.92 % 1315.23 %
Operating Income Growth 18.88 % -22.53 % 42.09 % 36.85 % -4.64 % 42.09 %
Operating Cash Flow Growth (CFG) 52.34 % -24.21 % 64.02 % 41.43 % -17.79 % 64.02 %
Operating 3 Year CFG 79.86 % -6.36 % 61.83 % 12.02 % -15.83 % 61.83 %
Operating 5 Year CFG 98.77 % 16.29 % 667.41 % 40.12 % 31.54 % 667.41 %
Operating 10 Year CFG 99 % 94.35 % 113.53 % 96.25 % -5.2 % 113.53 %
EPS Growth 30.98 % -16.24 % 140 % 33.87 % -24.53 % 140 %
EPS Diluted Growth 30.98 % -16.62 % 137.78 % 33.71 % -24.4 % 137.78 %
Book Value Per Share -239.97 % 6.01 % 8.01 % 11.49 % -1.1 % 8.01 %
Share Holder 3 Year Equity Growth Per Share -114.22 % 19.98 % 22.65 % 40.57 % 2.3 % 22.65 %
Share Holder 5 Year Equity Growth Per Share -124.25 % 27.6 % 110.04 % 56.21 % 3.56 % 110.04 %
Share Holder 10 Year Equity Growth Per Share 99.78 % 36.45 % 172.17 % 104.97 % 111.35 % 172.17 %
Dividend Per Share Growth - 8.27 % -49.88 % 7.97 % 7.9 % -49.88 %
Dividend 3 Year Growth Per Share - 41.54 % -2.5 % 30.56 % 25.97 % -2.5 %
Dividend 5 Year Growth Per Share - - - - 47.92 % -
Dividend 10 Year Growth Per Share - 258.71 % - 183.29 % 162.72 % -
Debt Growth -4.86 % -10.4 % 2.26 % -0.41 % 1.04 % 2.26 %
Free Cash Flow Growth 52.5 % -35.17 % 86.32 % 54.03 % -23.39 % 86.32 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 28 Apr 2023 31 Dec 2023
Profitability
VERO ABT BSX-PA SYK MDT BSX
Gross Profit Margin TTM 68.37 % 54.15 % 68.75 % 63.09 % 65.5 % 69.14 %
Return on Assets TTM -43.95 % 7.77 % 2.74 % 8.53 % 4.62 % 4.83 %
Return on Equity TTM 272.42 % 14.81 % 5.13 % 18.41 % 8.16 % 9.28 %
Return on Capital Employed TTM -50.18 % 11.54 % 6.66 % 12.73 % 6.98 % 7.82 %
Net Income Per EBT TTM 99.74 % 86.11 % 63.08 % 85.81 % 75.94 % 82.41 %
EBT Per Ebit TTM 134.29 % 96.92 % 74.52 % 94.87 % 97.81 % 86.51 %
EBIT Per Revenue TTM -38.08 % 16.73 % 14.71 % 19.7 % 17.5 % 16.89 %
Cash Flow To Debt Ratio TTM -12.61 % 48.97 % 18.94 % 26.97 % 25.75 % 22.52 %
Receivables Turnover TTM 2.7 6.11 6.28 6.04 5.42 6.38
Payables Turnover TTM 2.98 4.43 4.7 6.21 5.6 4.93
Inventory Turnover TTM 0.9 2.71 1.99 1.54 1.95 1.77
Fixed Asset Turnover TTM 1380.45 % 398.99 % 453.27 % 643.04 % 553.6 % 442.05 %
Asset Turnover TTM 86.16 % 55.65 % 39.66 % 53.2 % 35.58 % 40.11 %
Operating Cash Flow Per Share TTM -1.69 4.12 1.24 9.12 4.87 1.69
Free Cash Flow Per Share TTM -1.7 2.84 0.81 7.51 3.71 1.06
Cash Per Share TTM 87.27 % 383.55 % 39.7 % 632.75 % 625.78 % 276.42 %
Operating Cash Flow Sales Ratio TTM -13.44 % 17.71 % 13.6 % 16.55 % 20.02 % 16.84 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.72 % 68.92 % 65.5 % 82.36 % 76.21 % 62.7 %
Cash Flow Coverage Ratios TTM -12.61 % 48.97 % 18.94 % 26.97 % 25.75 % 22.52 %
Price To Free Cash Flows Ratio TTM -0.4 36.78 94.45 44.61 23.14 70.67
Price To Operating Cash Flows Ratio TTM -0.37 25.27 60.42 36.69 17.66 44.25
Price Cash Flow Ratio TTM -0.37 25.27 60.42 36.69 17.66 44.25
Income Statement (TTM)
VERO ABT BSX-PA SYK MDT BSX
Revenue $0.08B $40.11B $14.24B $20.5B $31.23B $14.24B
Gross Profit $0.05B $22.13B $9.9B $13.06B $20.51B $9.9B
Gross Profit Ratio 68.32% 55.18% 69.49% 63.7% 65.67% 69.49%
EBITDA $-0.02B $10.59B $3.62B $4.95B $9.04B $3.62B
Net Income $-0.04B $5.72B $1.59B $3.17B $3.76B $1.59B
EPS Diluted -6.84 3.26 1.07 8.25 2.82 1.07
Balance Sheet (MRQ)
VERO ABT BSX-PA SYK MDT BSX
Long Term Debt $0.07B $13.6B $8.96B $10.9B $24.34B $8.96B
Total Liabilities $0.11B $34.39B $15.61B $21.32B $39.28B $15.61B
Total Equity $-0.01B $38.83B $19.53B $18.59B $51.67B $19.53B
Total Investments $0.01B $1.18B $0.41B $0.08B $6.42B $0.41B
Total Debt $0.08B $15.87B $9.49B $13B $24.36B $9.49B
Total Assets $0.09B $73.21B $35.14B $39.91B $90.95B $35.14B
Cash Flow Statement (TTM)
VERO ABT BSX-PA SYK MDT BSX
Net Income $-0.04B $5.7B $1.59B $3.17B $3.78B $1.59B
Inventory $-0B $-0.23B $-0.66B $-0.8B $-0.94B $-0.66B
Dividends Paid $0B $-3.56B $-0.03B $-1.14B $-3.62B $-0.03B
Operating Cash Flow $-0.01B $7.26B $2.5B $3.71B $6.04B $2.5B
Capital Expenditure $-0B $-2.2B $-0.8B $-0.58B $-1.46B $-0.8B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 104.09
AEMD Aethlon Medical, Inc. 0.401
AFIB Acutus Medical, Inc. 0.059
AHCO AdaptHealth Corp. 9.98
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 271.5
ALUR Allurion Technologies Inc. 1.77
AMIX Autonomix Medical, Inc. Common Stock 2.5
ANIK Anika Therapeutics, Inc. 25.4
AORT Artivion, Inc. 23.46
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 1.6
ASXC Asensus Surgical, Inc. 0.26
ATEC Alphatec Holdings, Inc. 11.05
AVNS Avanos Medical, Inc. 20.39
AXDX Accelerate Diagnostics, Inc. 0.882
AXGN AxoGen, Inc. 6.04
AXNX Axonics, Inc. 67.55
AZYO Aziyo Biologics, Inc. 1.49
ETFs With Exposure to VERO
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 262.3
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 116.35
VXF Vanguard Extended Market Index Fund 0 173.42
IWC iShares Micro-Cap ETF 0 119.09
DFAU Dimensional US Core Equity Market ETF 0 36.84
VTSAX Vanguard Total Stock Market Index Fund 0 127.64
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 131.58
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 131.58
VEMPX Vanguard Extended Market Index InstlPlus 0 324.71
Unlock